PAVmed Inc PAVM

NAS: PAVM | ISIN: US70387R1068 30/04/2025

0,725 USD (-0,59%)

(-0,59%) 30/04/2025

Grafiek PAVmed Inc

Grafiek PAVmed Inc

1 dag1d -0,59%
1 week1w -3,99%
1 maand1m 3,51%
3 maanden3m 9,79%
6 maanden6m -29,44%
1 jaar1j -68,63%
5 jaar5j -64,48%

PAVmed Inc in het nieuws

Toon enkel gratis nieuws

30 april 2025 · Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 · Persbericht

24 april 2025 · NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD · Persbericht

11 april 2025 · Lucid Diagnostics Announces Closing of Public Offering of Common Stock · Persbericht

10 april 2025 · Lucid Diagnostics Announces Pricing of Public Offering of Common Stock · Persbericht

9 april 2025 · Lucid Diagnostics Announces Proposed Public Offering of Common Stock · Persbericht

3 april 2025 · Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference · Persbericht

27 maart 2025 · Lucid Diagnostics Launches "Embrace the Future" Campaign Showcasing EsoCheck's Groundbreaking Collect+Protect Esophageal Cell Collection Technology · Persbericht

25 maart 2025 · PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results · Persbericht

24 maart 2025 · Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results · Persbericht

20 maart 2025 · Lucid Diagnostics Announces Updated National Comprehensive Cancer Network® (NCCN) Guidelines Now Include Esophageal Precancer Screening · Persbericht

Profiel PAVmed Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.pavm.com

Hoofdzetel: New York, New York Verenigde Staten

Werknemers: 57

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe